TrialPloS one2025

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.

Andrew F Shorr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.